Merseburger, A., Carl, S., Feyerabend, S., Gleissner, J., Grimm, M. -O., Gruellich, C., Heidenreich, A., Heinrich, B., Miller, K., Stenzl, A., Steuber, T., Wirth, M., Watkins, S., Simmons, A., Passler, L., Shetty, S., Golsorkhi, T., Ryan, C. and Chowdhury, S. (2018). TRITON3: An International, Randomised, Open-Label Phase 3 Study of the PARP Inhibitor Rucaparib vs Physician's Choice of Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Associate with Homologous Recombination Deficiency (HRD). Oncol. Res. Treat., 41. S. 74 - 75. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Merseburger, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Carl, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Feyerabend, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gleissner, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grimm, M. -O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gruellich, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heidenreich, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heinrich, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Miller, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stenzl, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Steuber, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wirth, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Watkins, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Simmons, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Passler, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Shetty, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Golsorkhi, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ryan, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Chowdhury, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-203653
Journal or Publication Title: Oncol. Res. Treat.
Volume: 41
Page Range: S. 74 - 75
Date: 2018
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/20365

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item